BIIB Latest Headlines

Biogen: Incremental Pipeline Progress and Spinraza Update Support Hold Rating Amid Ongoing Uncertainties

at www.tipranks.com (Tue, 31-Mar 4:46 AM)

Biogen Stock Pops After FDA Approves New High-Dose Spinraza For Spinal Muscular Atrophy

at www.benzinga.com (Mon, 30-Mar 1:40 PM)

Biogen receives FDA approval for high-dose Spinraza regimen

at seekingalpha.com (Mon, 30-Mar 12:07 PM)

Biogen (BIIB) Gets a Buy from Canaccord Genuity

at www.tipranks.com (Mon, 30-Mar 9:35 AM)

Biogen (Litifilimab/Lupus): Encouraging Early Data but Competitive and Clinical Risks Support a Neutral Hold

at www.tipranks.com (Mon, 30-Mar 7:15 AM)

Balanced but Constrained Upside: Hold Rating on Biogen as Modest Litifilimab Data Meet Rising Lupus Competition

at www.tipranks.com (Mon, 30-Mar 6:26 AM)

Analysts Offer Insights on Healthcare Companies: Biogen (BIIB) and TSURUHA Holdings (OtherTSUSF)

at www.tipranks.com (Mon, 30-Mar 6:10 AM)

Analysts Offer Insights on Healthcare Companies: Biogen (BIIB) and Kezar Life Sciences (KZR)

at www.tipranks.com (Mon, 30-Mar 4:40 AM)

Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (DH) and Biogen (BIIB)

at www.tipranks.com (Sun, 29-Mar 9:20 PM)

Biogen Advances Litifilimab Delivery Study, Sharpening Its Autoimmune Launch Strategy

at www.tipranks.com (Fri, 27-Mar 12:33 PM)